Nanodigmbio @ INTERPHEX Week Tokyo 2023

On July 5-7, 2023, the three-day Japan International Pharmaceutical R&D and Pharmaceutical Technology Expo (INTERPHEX Week Tokyo) successfully concluded at Tokyo Big Sight International Exhibition Center in Tokyo, Japan! INTERPHEX Week Tokyo provided an important platform for industry professionals to facilitate exchange and collaboration, offering opportunities to explore the Japanese and international markets. As one of Asia's leading comprehensive industry events, INTERPHEX aims to integrate industry innovation with expert-led technical conferences. Numerous industry experts participated in the exhibition, conducting business negotiations during the event, and 150 invited guests delivered captivating speeches at the summit forum. Here, new technologies and products were showcased, and the power of science was realized through commercialization!

Event Highlights

The event attracted approximately 850 exhibitors from around the world and about 30,000 professional attendees. During the exhibition, exhibitors focused on showcasing new technologies and products related to global manufacturing and processing, biopharmaceuticals, drug development, APIs/pharmaceutical raw materials, and more. The exhibits comprehensively covered the entire pharmaceutical R&D, production, and service industry.Additionally, the conference invited representatives from well-known industry enterprises who shared their latest research findings, showcased cutting-edge R&D and manufacturing technologies, and collectively discussed hot topics in pharmaceutical R&D and pharmaceutical technology.

Nanodigmbio moments

During this event, Nanodigmbio presented its innovative μCaler MRD Solution, personalized probe customization services, and NGS integrated solutions, attracting considerable attention from the audience. Throughout the three-day exhibition, visitors crowded around theNanodigmbio booth. Nanodigmbio's marketing team introduced high-throughput sequencing technology, product application directions, and technical advantages to the participating audience through professional explanations and patient communication. Furthermore, Nanodigmbio's sales team engaged in in-depth conversations with peers deeply involved in the NGS genetic testing field, seeking further collaboration opportunities and expanding business in the Japanese market.